Early Phase Cancer Immunotherapy / edited by Sandip Pravin Patel, Razelle Kurzrock.
Colaborador(es): Patel, Sandip Pravin, editor literario | Kurzrock, Razelle, editor literario
| SpringerLink (Online service).
Tipo de material: 
E-bookSeries (Current Cancer Research, 2199-2584); (Medicine (Springer-11650)).Editor: Cham : Springer International Publishing : Imprint: Springer, 2018Descripción: 1 recurso en línea (XI, 331 páginas 24 ilustraciones, 15 ilustraciones a color).ISBN: 9783319637570.Tema: Oncología | InmunoterapiaRecursos en línea: Acceso a este recurso digital (usuarios Universidad Europea de Valencia)
| Tipo de ítem | Biblioteca actual | Colección | Signatura topográfica | Estado | Fecha de vencimiento | Código de barras | Reserva de ítems | |
|---|---|---|---|---|---|---|---|---|
LIBRO-E NO PRÉSTAMO
|
Valencia Digital Acceso Electrónico (UEV) | Ciencias de la Salud | RC271 .E275 2018 EB (Navegar estantería(Abre debajo)) | Acceso electrónico |
Chapter 1 Primer on Cancer Immunotherapy and the Targeting of Native Proteins -- Chapter 2 Pharmacokinetics and Pharmacodynamics of Immunotherapy -- Chapter 3 Immunotherapeutic Biomarkers and Selection Strategies -- Chapter 4 Radiographic Evaluation of Immunotherapy -- Chapter 5 Cellular Therapy -- Chapter 6 Combinatorial Checkpoint Blockade Immunotherapy and Radiation -- Chapter 7 Early Phase Cancer Immunotherapy -- Chapter 8 Immune Checkpoint Combinations with Inflammatory Pathway Modulators -- Chapter 9 Combinations of Genomically and Immune-Targeted Therapies in Early-Phase Clinical Trials -- Chapter 10 Thoracic Immunotherapy.
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.
No hay comentarios en este titulo.